G. H. Lyman, A. E. Giuliano, M. R. Somerfield, . Benson, D. C. Bodurka et al., American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer, J Clin Oncol, vol.23, pp.7703-7723, 2005.

D. N. Krag, S. J. Anderson, T. B. Julian, A. M. Brown, S. P. Harlow et al., Sentinel-lymph-node resection compared with conventional axillary-lymphnode dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial, Lancet Oncol, vol.11, pp.927-960, 2010.

A. E. Giuliano, K. K. Hunt, K. V. Ballman, P. D. Beitsch, P. W. Whitworth et al., Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial, JAMA, vol.305, pp.569-75, 2011.

V. Galimberti, B. F. Cole, S. Zurrida, G. Viale, A. Luini et al., Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial, Lancet Oncol, vol.14, pp.297-305, 2013.

D. Friedman, M. Gipponi, F. Murelli, P. Meszaros, N. Solari et al., Predictive factors of non-sentinel lymph node involvement in patients with invasive breast cancer and sentinel node micrometastases, Anticancer Res, vol.33, pp.4509-4523, 2013.

D. E. Rivadeneira, R. M. Simmons, P. J. Christos, K. Hanna, J. M. Daly et al., Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: analysis in more than 900 patients, J Am Coll Surg, vol.191, pp.1-6, 2000.

M. C. González-vela, M. F. Garijo, F. A. Fernández, L. Buelta, and J. F. Val-bernal, Predictors of axillary lymph node metastases in patients with invasive breast carcinoma by a combination of classical and biological prognostic factors, Pathol Res Pract, vol.195, pp.611-619, 1999.

T. Fehm, H. Maul, S. Gebauer, A. Scharf, P. Baier et al., Prediction of axillary lymph node status of breast cancer patients by tumor biological factors of the primary tumor, Strahlenther Onkol, vol.181, pp.580-586, 2005.

C. H. Yip, N. A. Taib, G. H. Tan, K. L. Ng, B. K. Yoong et al., Predictors of axillary lymph node metastases in breast cancer: is there a role for minimal axillary surgery?, World J Surg, vol.33, pp.54-61, 2009.

A. A. Bader, J. Tio, E. Petru, M. Bühner, A. Pfahlberg et al., T1 breast cancer: identification of patients at low risk of axillary lymph node metastases, Breast Cancer Res Treat, vol.76, pp.11-18, 2002.

F. Reyal, R. Rouzier, B. Depont-hazelzet, M. A. Bollet, J. Y. Pierga et al., The molecular subtype classification is a determinant of sentinel node positivity in early breast carcinoma, PLoS One, vol.6, p.20297, 2011.

X. Lu, X. Lu, Z. C. Wang, J. D. Iglehart, X. Zhang et al., Predicting features of breast cancer with gene expression patterns, Breast Cancer Res Treat, vol.108, pp.191-201, 2008.

S. J. Crabb, M. C. Cheang, S. Leung, T. Immonen, T. O. Nielsen et al., Basal breast cancer molecular subtype predicts for lower incidence of axillary lymph node metastases in primary breast cancer, Clinical Breast Cancer, vol.8, pp.249-56, 2008.

B. Van-calster, V. Bempt, I. Drijkoningen, M. Pochet, N. Cheng et al., Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive, Breast Cancer Res Treat, vol.113, pp.181-188, 2009.

J. H. Lee, S. H. Kim, Y. J. Suh, B. Y. Shim, and H. K. Kim, Predictors of axillary lymph node metastases (ALNM) in a Korean population with T1-2 breast carcinoma: triple negative breast cancer has a high incidence of ALNM irrespective of the tumor size, Cancer Res Treat, vol.42, pp.30-36, 2010.

M. J. Kim, J. Y. Ro, S. H. Ahn, H. H. Kim, S. B. Kim et al., Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes, Hum Pathol, vol.37, pp.1217-1243, 2006.

C. Ngo, D. Mouttet, Y. De-rycke, F. Reyal, V. Fourchotte et al., Validation over time of a nomogram including HER2 status to predict the sentinel node positivity in early breast carcinoma, Eur J Surg Oncol, vol.38, pp.1211-1218, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00750147

A. Goldhirsch, W. C. Wood, A. S. Coates, R. D. Gelber, B. Thürlimann et al., Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen international expert consensus on the primary therapy of early breast Cancer, Ann Oncol, vol.22, pp.1736-1783, 2011.

G. Von-minckwitz, M. Untch, J. U. Blohmer, S. D. Costa, H. Eidtmann et al., Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes, J Clin Oncol, vol.30, pp.1796-804, 2012.

G. Houvenaeghel, A. Goncalves, J. M. Classe, J. R. Garbay, S. Giard et al., Characteristics and clinical outcome of T1 breast cancer: a multicenter retrospective cohort study, Ann Oncol, 2014.

F. E. Harrell, Regression Modeling Strategies with Applications to Linear Models, Logistic Regression and Survival Analysis, p.568, 2001.

T. A. Gerds, T. Cai, and M. Schumacher, The performance of risk prediction models, Biom J, issue.4, pp.457-79, 2008.

X. Robin, N. Turck, A. Hainard, N. Tiberti, F. Lisacek et al., pROC: an open-source package for R and S+ to analyze and compare ROC curves, BMC Bioinformatics, vol.12, p.77, 2011.

D. W. Hosmer and S. Lemeshow, Applied logistic regression, Second Edition, 2000.

J. E. Mendez, J. V. Fey, H. Cody, P. I. Borgen, and L. M. Sclafani, Can sentinel lymph node biopsy be omitted in patients with favorable breast cancer histology?, Ann Surg Oncol, vol.12, pp.24-32, 2005.

G. Houvenaeghel, R. Sabatier, F. Reyal, J. M. Classe, S. Giard et al., Axillary lymph node micrometastases decrease triple-negative early breast cancer survival, Br J Cancer, vol.115, issue.9, pp.1024-1055, 2016.

G. Martelli, R. Miceli, M. G. Daidone, G. Vetrella, A. M. Cerrotta et al., Axillary dissection versus no axillary dissection in elderly patients with breast cancer and no palpable axillary nodes: results after 15 years of follow-up, Ann Surg Oncol, vol.18, pp.125-158, 2011.

V. Forissier, A. Tallet, M. Cohen, J. M. Classe, F. Reyal et al., Is post-mastectomy radiation therapy contributive in pN0-1mi breast cancer patients? Results of a French multi-centric cohort, Eur J Cancer, vol.87, pp.47-57, 2017.